Weight Loss for Obese Prostate Cancer Patients on Androgen Deprivation Therapy

PURPOSE: Excess fat mass (FM) contributes to poor prostate cancer (PCa) prognosis and comorbidity. However, FM gain is a common side effect of androgen deprivation therapy (ADT). We examined the efficacy of a 12-wk weight loss intervention to reduce FM and maintain lean mass (LM) in ADT-treated obes...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Med Sci Sports Exerc
Autors principals: WILSON, REBEKAH L., NEWTON, ROBERT U., TAAFFE, DENNIS R., HART, NICOLAS H., LYONS-WALL, PHILIPPA, GALVÃO, DANIEL A.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2021
Matèries:
Clinical Sciences
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7886363/
https://ncbi.nlm.nih.gov/pubmed/33009195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1249/MSS.0000000000002509
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars